Short Bias
Short only, contrarian

Short AmerisourceBergen: There's No Easy Cure For What Ails This Drug Wholesaler

In the aftermath of the Affordable Care Act's passage, the smart money began scouring for companies that would benefit from the Act's implementation. Many wise asset managers honed in on the pharmaceutical wholesalers - The Big Three, as they are known. On the surface, the sector and its players seemed to be well-positioned: 90%+ market share concentrated in three companies, high barriers to entry, and robust underlying growth trends - e.g., an aging US population and an explosion in both specialty and generic pharmaceutical products for sale.

Over the last three years, share prices of each have grown substantially: McKesson (NYSE:MCK) 132%+, Cardinal Health (NYSE:CAH) 68%+, and AmerisourceBergen (NYSE:ABC) 77%...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details